Cited by 33Neuroscience and Neuropharmacology ResearchMemory and Neural MechanismsIon channel regulation and function

Bidirectional Influence of Limbic GIRK Channel Activation on Innate Avoidance Behavior

Open access
Vo, Baovi N., Marron Fernandez de Velasco, Ezequiel, Rose, Timothy R., Oberle, Hannah, Luo, Haichang, Hopkins, Corey R., Wickman, Kevin·2021·The Journal of Neuroscience

Abstract

Systemic administration of ML297, a selective activator of G-protein-gated inwardly rectifying K+ (GIRK) channels, decreases innate avoidance behavior in male C57BL/6J mice. The cellular mechanisms mediating the ML297-induced suppression of avoidance behavior are unknown. Here, we show that systemic ML297 administration suppresses elevated plus maze (EPM)-induced neuronal activation in the ventral hippocampus (vHPC) and basolateral amygdala (BLA) and that ML297 activates GIRK1-containing GIRK channels in these limbic structures. While intracranial infusion of ML297 into the vHPC suppressed avoidance behavior in the EPM test, mirroring the effect of systemic ML297, intra-BLA administration of ML297 provoked the opposite effect. Using neuron-specific viral genetic and chemogenetic approaches, we found that the combined inhibition of excitatory neurons in CA3 and dentate gyrus (DG) subregions of the vHPC was sufficient to decrease innate avoidance behavior in the EPM, open-field, and light-dark tests in male C57BL/6J mice, while performance in the marble-burying test was not impacted. Furthermore, genetic ablation of GIRK channels in CA3/DG excitatory neurons precluded the suppression of avoidance behavior evoked by systemic ML297 in the EPM test. Thus, acute inhibition of excitatory neurons in the ventral CA3 and DG subregions of the vHPC is necessary for the apparent anxiolytic efficacy of systemic ML297 and is sufficient to decrease innate avoidance behavior in male C57BL/6J mice. SIGNIFICANCE STATEMENT We interrogated the cellular mechanisms underlying the apparent anxiolytic efficacy of ML297, a selective activator of G-protein-gated inwardly rectifying K+ (GIRK) channels and promising lead compound. Intracranial infusion of ML297 into the ventral hippocampus (vHPC) and basolateral amygdala (BLA) complex exerted opposing influence on innate avoidance behavior in male C57BL/6J mice, the former recapitulating the suppression of avoidance behavior evoked by systemic ML297. Using viral genetic and chemogenetic approaches, we showed that combined inhibition of excitatory neurons in CA3 and dentate gyrus (DG) subregions of the vHPC is sufficient to decrease innate avoidance behavior in male mice and mediates the decrease in avoidance behavior evoked by systemic ML297. These findings establish a foundation for future investigations into the therapeutic potential of GIRK channel modulation in anxiety disorders.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1523/jneurosci.2787-20.2021

Cites

74 of 74 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Selective GIRK1/2 channel openers including ML297 and GAT1508 hyperpolarize principal neurons, reduce avoidance and anxiety-like behaviors, and facilitate extinction of conditioned fear without motor or cardiac liabilities.

    “Selective GIRK1/2 channel openers, including ML297, a prototype small-molecule GIRK1/2 activator, and GAT1508, a next-generation brain-penetrant GIRK1/2 modulator, hyperpolarize principal neurons, reduce avoidance and anxiety-like behaviors, and facilitate extinction of conditioned fear without motor or cardiac liabilities”

    From Synaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery (2026) · cites this paper as [314]

    The Introduction (page not provided) identifies ML297 as a GIRK1-containing channel activator and reports reduced innate avoidance without altered motor activity. The results section on intracranial ML297 (page not provided) qualifies that finding: infusion into the ventral hippocampus reduced avoidance, whereas infusion into the basal amygdala increased it. Our copy reports ML297-induced currents in excitatory neurons, but does not establish the claim about GAT1508, conditioned-fear extinction, or absence of cardiac liabilities. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • Pharmacological activation of GIRK channels delivers a coherent anti-agitation profile by lowering pyramidal cell gain and stabilizing limbic rhythms.

    “Pharmacological activation of GIRK channels delivers a coherent anti-agitation profile by lowering pyramidal cell gain and stabilizing limbic rhythms [305,314].”

    From Synaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery (2026) · cites this paper as [314]

    The electrophysiology results report GIRK-dependent currents in ventral hippocampal pyramidal neurons, and the Discussion reports that GIRK activation in the ventral hippocampus decreased innate avoidance in male mice. But activation in the basal amygdala increased avoidance, so the behavioral effect is not uniformly anti-agitation. The paper does not report stabilization of limbic rhythms, and innate avoidance in mice is not the same outcome as agitation. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Vo, B. N., Marron Fernandez de Velasco, E., Rose, T. R., Oberle, H., Luo, H., Hopkins, C. R., & Wickman, K.
Affiliations
  • University of Minnesota (US)
  • University of Nebraska Medical Center (US)
Venue
The Journal of Neuroscience
Published
2021-05-26
Volume
41
Issue
27
Pages
5809-5821
ISSN
  • 0270-6474 (ISSN-L)
  • 1529-2401
OpenAlex
W3165477014
Cited by
33
References
73
Citations by year
2026: 1 · 2025: 4 · 2024: 26 · 2022: 2
FWCI
3.23
Type
journal article
Language
en
Open access
Locations
  • Journal of Neuroscience (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (DA007234)
  • National Institute on Alcohol Abuse and Alcoholism (R01AA027544)
  • National Institute of Mental Health (R01MH107399)
  • National Institute on Drug Abuse (R01DA034696, T32DA007234)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Memory and Neural Mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
Keywords
G protein-coupled inwardly rectifying potassium channels, GIRK1, anxiolytic efficacy, ventral hippocampus, basolateral amygdala, CA3, dentate gyrus, excitatory neurons, elevated plus maze, chemogenetic inhibition, viral gene delivery, marble-burying behavior

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review